Author

Anjali Singh

7

Articles

Articles

Manipal Health launches India's biggest healthcare IPO at ₹560-590 a share

Manipal Health launches India's biggest healthcare IPO at ₹560-590 a share

₹9,275-crore issue opens on July 29 as the Temasek-backed hospital chain plans to add around 3,000 beds through greenfield and brownfield projects

Read Article
Takeda gets DCGI approval for QDENGA, India's first dengue vaccine

Takeda gets DCGI approval for QDENGA, India's first dengue vaccine

The vaccine has been approved for individuals aged 4-60 years and can be administered without prior dengue screening, marking India's first vaccine-based strategy against the disease

Read Article
Sun Pharma's Unloxcyt posts 50% response rate in skin cancer study

Sun Pharma's Unloxcyt posts 50% response rate in skin cancer study

Updated data from the CK-301-101 trial showed durable responses and manageable safety profile in patients with locally advanced cutaneous squamous cell carcinoma

Read Article
FIEO urges RBI to provide liquidity support amid West Asia conflict

FIEO urges RBI to provide liquidity support amid West Asia conflict

India's export sector has held up well despite a year marked by geopolitical tensions, tariff volatility, said SBI's Ghosh

Read Article
Budget 2026: Govt to set up 5 medical tourism hubs, train 150K caregivers

Budget 2026: Govt to set up 5 medical tourism hubs, train 150K caregivers

Finance Minister Nirmala Sitharaman announced measures in the Union Budget 2026-27 to boost medical tourism, including support for five regional hubs in partnership with states and the private sector

Read Article
Medical emergencies drive urban Indians to personal loans, says study

Medical emergencies drive urban Indians to personal loans, says study

Rising medical costs and insurance gaps are pushing more urban Indians to take personal loans for healthcare, with reliance highest in Tier-I cities, a Paisabazaar study shows

Read Article
Precision oncology gains ground as India clears targeted cancer therapies

Precision oncology gains ground as India clears targeted cancer therapies

A string of CDSCO approvals and reviews is accelerating India's move to immunotherapies, ADCs and targeted drugs, widening options in major cancers and boosting competition

Read Article